Detalles de la búsqueda
1.
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
Cell Mol Life Sci
; 79(4): 204, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332383
2.
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.
Cancer Immunol Immunother
; 69(5): 771-777, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32047958
3.
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer.
Biomed Pharmacother
; 155: 113695, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126454
4.
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Eur J Cancer
; 174: 113-120, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35988409
5.
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Eur J Cancer
; 144: 41-48, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326868
6.
The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab.
J Cachexia Sarcopenia Muscle
; 12(3): 657-664, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951326
7.
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy.
Cancers (Basel)
; 13(6)2021 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803602
8.
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34088739
9.
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33093157
10.
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors.
Clin Cancer Res
; 26(19): 5188-5197, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631957
11.
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.
Lung Cancer
; 146: 341-349, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645666
12.
Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.
Thyroid
; 30(7): 966-973, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32151195
13.
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32461348
14.
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
J Immunother Cancer
; 8(2)2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427690
15.
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
J Immunother Cancer
; 7(1): 182, 2019 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300068
16.
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen.
Cancers (Basel)
; 11(3)2019 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30909366
17.
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.
Eur J Cancer
; 109: 12-20, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30654225
18.
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.
J Immunother Cancer
; 7(1): 192, 2019 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324223
19.
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
J Immunother Cancer
; 7(1): 149, 2019 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31176366
Resultados
1 -
19
de 19
1
Próxima >
>>